Zobrazeno 1 - 10
of 27
pro vyhledávání: '"John Zachary Sanborn"'
Autor:
Michael P. Lux, Shahrooz Rabizadeh, Andy Nguyen, John Zachary Sanborn, Andreas Mackensen, Marieke Griffioen, Sebastian M. Jud, PA Fasching, Steve Benz, H Hübner, M. W. Beckmann, ED Van der Meijden, H Reimann, R Erber, Matthias Rübner, Judith Bausenwein, Anita N. Kremer, C Rauh
Publikováno v:
Cancer Research. 79:P2-09
Background: Recent studies have demonstrated that the number of tumor infiltrating lymphocytes (TILs) positively correlates with outcome and response to chemotherapy in patients with HER2+ and Triple-Negative Breast Cancer (TNBC). Furthermore, first
Autor:
Bruno Valentin Sinn, Theresa Link, V Müller, F Marmé, S. Loibl, M. van Mackelenbergh, Stephen C. Benz, Michael Untch, Ernst Heinmöller, Karsten Weber, Wolfgang D. Schmitt, Andreas Schneeweiss, Elmar Stickeler, Hans-Peter Sinn, Thomas Karn, John Zachary Sanborn, Christian Schem, Peter A. Fasching, J. Golovato, Jan Budczies, Patrick Soon-Shiong, R. Parulkar, Paul Jank, Sabine Schmatloch, Carsten Denkert, C. Jackisch, Valentina Nekljudova, Shahrooz Rabizadeh
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 32(4)
Different endogenous and exogenous mutational processes act over the evolutionary history of a malignant tumor, driven by abnormal DNA editing, mutagens or age-related DNA alterations, among others, to generate the specific mutational landscape of ea
Autor:
Taekyu Kang, Christopher C. Benz, Josh Stuart, John Zachary Sanborn, Stephen C. Benz, Jill E. Henry, Christopher K. Wong, Yulia Newton, Charles J. Vaske, Christina Yau, Gregor Krings, Roman Camarda, Mark Powell
Publikováno v:
Breast Cancer Research : BCR
Breast cancer research : BCR, vol 22, iss 1
Breast Cancer Research, Vol 22, Iss 1, Pp 1-15 (2020)
Breast cancer research : BCR, vol 22, iss 1
Breast Cancer Research, Vol 22, Iss 1, Pp 1-15 (2020)
Background Previous studies have identified and validated a risk-associated Active transcriptome phenotype commonly expressed in the cancer-adjacent and histologically normal epithelium, stroma, and adipose containing peritumor microenvironment of cl
Autor:
Charles Zaloudek, John Zachary Sanborn, Paul T. Spellman, Raymond J. Cho, Joseph T. Rabban, Stephen C. Benz, David A. Solomon, Christopher Boniface, Michael B. Heskett, Jocelyn S. Chapman, Benjamin Goode, Karuna Garg
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol 33, iss 6
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Immature teratoma is a subtype of malignant germ cell tumor of the ovary that occurs most commonly in the first three decades of life, frequently with bilateral ovarian disease. Despite being the second most common malignant germ cell tumor of the ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7542db210e7d4d6a6a10f9a4606708b
https://escholarship.org/uc/item/02m6w9w7
https://escholarship.org/uc/item/02m6w9w7
Autor:
John Zachary Sanborn, Shahrooz Rabizadeh, Stephen C. Benz, Patrick Soon-Shiong, Chad Garner, Sandeep K. Reddy
Publikováno v:
Oncotarget
A CMS approved test for lung cancer is based on tumor-only analysis of a targeted 35 gene panel, specifically excluding the use of the patient’s normal germline tissue. However, this tumor-only approach increases the risk of mistakenly identifying
Autor:
Charles Zaloudek, Paul T. Spellman, Stephen C. Benz, Raymond J. Cho, David A. Solomon, Christopher Boniface, John Zachary Sanborn, Benjamin Goode, Jocelyn Chapman, Michael B. Heskett, Joseph T. Rabban, Karuna Garg
Immature teratoma is a subtype of malignant germ cell tumor of the ovary that occurs most commonly in the first three decades of life, frequently with bilateral ovarian disease. Despite being the second most common malignant germ cell tumor of the ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39171b608777a2d8553602d9392165b
https://doi.org/10.1101/818534
https://doi.org/10.1101/818534
Autor:
Angelo Paolo Dei Tos, Roberto Filippi, Matteo Fassan, Marta Schirripa, Giada Munari, Pasquale Lombardi, Alessandra Anna Prete, John Zachary Sanborn, Massimo Rugge, Paola Biason, Andrew Anh Nguyen, Andrea Spallanzani, Nicola Valeri, Roberta Salmaso, Giulia Maddalena, Luis Zapata, Andrea Sottoriva, Rossana Intini, Sara Lonardi, Luca Reggiani Bonetti, Ilaria Depetris, Justin Golovato, Fotios Loupakis, Stefano Cascinu, Vittorina Zagonel, Francesco Leone
Publikováno v:
Oncologist
Background Immunotherapy with immune checkpoint inhibitors (ICIs) is highly effective in microsatellite instability–high (MSI-H) metastatic colorectal cancer (mCRC); however, specific predictive biomarkers are lacking. Patients and Methods Data and
Autor:
Peter Ordentlich, Claudia Palena, Karin L. Lee, John Zachary Sanborn, Rohlin Lars Erik Ulf, Zhen Su, Andrew Anh Nguyen, Duane H. Hamilton, Kristin C. Hicks, Shahrooz Rabizadeh, Sofia R. Gameiro, Jeffrey Schlom, Kayvan Niazi, Stephen C. Benz, John H. Lee, Patrick Soon-Shiong
Publikováno v:
Cancer Immunol Res
Progressive tumor growth is associated with deficits in the immunity generated against tumor antigens. Vaccines targeting tumor neoepitopes have the potential to address qualitative defects; however, additional mechanisms of immune failure may underl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff30dd172fa8c3e069c282b9297ee60b
https://europepmc.org/articles/PMC8202970/
https://europepmc.org/articles/PMC8202970/
Autor:
Diaz F Lopez, Charles J. Vaske, W Lee, Nader Pourmand, John Zachary Sanborn, Steve Benz, Beverly M. Emerson
Publikováno v:
Cancer Research. 72:P2-06
Cancer treatments act on a population of cells, each of which may experience different individual responses to treatment. Such differential response will result in resistance to treatment even if a majority of cancerous cells are eliminated. To exami
Publikováno v:
Cancer Research. 71:P3-06
Cancer is a disease of genomic perturbations that lead to dysregulation of multiple pathways within the cellular system. While common pathways are believed to be shared within specific cancer types, the mechanisms behind why particular patients respo